353 related articles for article (PubMed ID: 11176955)
1. Synucleinopathies: clinical and pathological implications.
Galvin JE; Lee VM; Trojanowski JQ
Arch Neurol; 2001 Feb; 58(2):186-90. PubMed ID: 11176955
[TBL] [Abstract][Full Text] [Related]
2. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
3. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM
Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.
Paleologou KE; Oueslati A; Shakked G; Rospigliosi CC; Kim HY; Lamberto GR; Fernandez CO; Schmid A; Chegini F; Gai WP; Chiappe D; Moniatte M; Schneider BL; Aebischer P; Eliezer D; Zweckstetter M; Masliah E; Lashuel HA
J Neurosci; 2010 Mar; 30(9):3184-98. PubMed ID: 20203178
[TBL] [Abstract][Full Text] [Related]
5. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.
Dev KK; Hofele K; Barbieri S; Buchman VL; van der Putten H
Neuropharmacology; 2003 Jul; 45(1):14-44. PubMed ID: 12814657
[TBL] [Abstract][Full Text] [Related]
6. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Spillantini MG; Goedert M
Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
[TBL] [Abstract][Full Text] [Related]
7. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
Peelaerts W; Baekelandt V
J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein and neurodegenerative diseases.
Goedert M
Nat Rev Neurosci; 2001 Jul; 2(7):492-501. PubMed ID: 11433374
[No Abstract] [Full Text] [Related]
9. [Analysis of alpha-synuclein and its significance].
Nonaka T; Iwatsubo T; Hasegawa M
Nihon Rinsho; 2004 Sep; 62(9):1623-8. PubMed ID: 15462375
[TBL] [Abstract][Full Text] [Related]
10. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
Fujiwara H; Hasegawa M; Dohmae N; Kawashima A; Masliah E; Goldberg MS; Shen J; Takio K; Iwatsubo T
Nat Cell Biol; 2002 Feb; 4(2):160-4. PubMed ID: 11813001
[TBL] [Abstract][Full Text] [Related]
11. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
12. Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.
Hishikawa N; Niwa J; Doyu M; Ito T; Ishigaki S; Hashizume Y; Sobue G
Am J Pathol; 2003 Aug; 163(2):609-19. PubMed ID: 12875980
[TBL] [Abstract][Full Text] [Related]
13. [Alpha-synucleinopathies].
Ferrer I
Neurologia; 2001 Apr; 16(4):163-70. PubMed ID: 11412709
[TBL] [Abstract][Full Text] [Related]
14. Alpha synuclein in neurodegenerative disorders: murderer or accomplice?
Mezey E; Dehejia A; Harta G; Papp MI; Polymeropoulos MH; Brownstein MJ
Nat Med; 1998 Jul; 4(7):755-7. PubMed ID: 9662355
[No Abstract] [Full Text] [Related]
15. Up-regulation of SNCA gene expression: implications to synucleinopathies.
Tagliafierro L; Chiba-Falek O
Neurogenetics; 2016 Jul; 17(3):145-57. PubMed ID: 26948950
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies.
Sampathu DM; Giasson BI; Pawlyk AC; Trojanowski JQ; Lee VM
Am J Pathol; 2003 Jul; 163(1):91-100. PubMed ID: 12819014
[TBL] [Abstract][Full Text] [Related]
17. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
18. Genetics of Synucleinopathies.
Nussbaum RL
Cold Spring Harb Perspect Med; 2018 Jun; 8(6):. PubMed ID: 28213435
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease and other alpha-synucleinopathies.
Goedert M
Clin Chem Lab Med; 2001 Apr; 39(4):308-12. PubMed ID: 11388653
[TBL] [Abstract][Full Text] [Related]
20. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
Wales P; Pinho R; Lázaro DF; Outeiro TF
J Parkinsons Dis; 2013; 3(4):415-59. PubMed ID: 24270242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
